KRTAP9-12P

Across TCGA pan-cancer cohorts, KRTAP9-12P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated KRTAP9-12P data layer.

The strongest signal is observed in thymoma (THYM), where higher KRTAP9-12P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRTAP9-12P expression acts as an unfavorable survival marker, although some lineages such as UCS and CESC show a favorable association.

THYM, LIHC, and KICH are the cancer types where KRTAP9-12P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	DFS	Tertile	All	0.410	0.782	<.001	90	view →
LIHC	DFS	Tertile	All	0.316	0.565	<.001	87	view →
KICH	DFS	Tertile	All	0.035	0.900	<.001	72	view →
KIRC	DFS	Tertile	III,IV	0.455	0.663	.003	63	view →
UCS	OS	Tertile	II,III,IV	0.765	0.286	.013	54	view →
HNSC	DFS	Tertile	All	0.343	0.592	.005	36	view →
LUAD	OS	Tertile	All	0.733	0.823	.012	33	view →
BLCA	DFS	Tertile	II,III,IV	0.444	0.644	.002	24	view →
CESC	DFS	Tertile	All	0.884	0.795	.019	12	view →
KIRP	DFS	Tertile	All	0.675	0.873	.020	12	view →
MESO	DFS	Tertile	All	0.166	0.372	.026	9	view →
PCPG	DFS	Tertile	All	0.070	0.936	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

KRTAP9-12P–THYM (DFS)

Open the THYM breakdown →